A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it.
Read more http://www.alphagalileo.org/ViewItem.aspx?ItemId=148131&CultureCode=en
| < Prev | Next > |
|---|
